Introduction: Adjuvant platinum based chemotherapy is accepted as standard of care in
stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in …

Introduction: An international database was collected to inform the 8 th edition of the
anatomic classification of lung cancer. The present analyses concern its primary tumor (T) …

BACKGROUND Visceral pleural invasion (VPI) is considered an aggressive and invasive
factor in non-small cell lung cancer (NSCLC). Recent studies found that depending on tumor …

Background The prognostic effect of visceral pleural invasion remains controversial when a
tumor is less than 3 cm in stage I non-small cell lung cancer patients. We conducted this …

Therapy of non-small cell lung cancer (NSCLC) patients has evolved over the past few years
with the incorporation of targeted therapy and immune therapy. These changes have …

Background: c-MYC copy number gain (c-MYC gain) has been associated with aggressive
behaviour in several cancers. However, the role of c-MYC gain has not yet been determined …

Objectives The detection rate of small pulmonary nodules has recently increased and new
techniques have been developed to improve diagnostic yield. The IASLC/ATS/ERS …

Background Reports on the prognosis for 5-year survivors with lung adenocarcinoma after
resection are sparse. This study aimed to identify factors associated with overall survival …

Importance Despite recent breakthroughs in therapy, advanced lung cancer still poses a
therapeutic challenge. The survival profile of patients with metastatic lung cancer remains …

Background Integrated 18F-fluorodeoxyglucose positron emission tomography/computed
tomography (18F-FDG PET/CT) is widely performed in hilar and mediastinal lymph node …